Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACET | Common Stock | Options Exercise | $45.5K | +7.62K | +12.72% | $5.97 | 67.5K | Apr 1, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Sale | -$160K | -7.62K | -11.28% | $21.00* | 59.9K | Apr 1, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Options Exercise | $80.1K | +6.04K | +10.07% | $13.27* | 66K | Apr 4, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Sale | -$127K | -6.04K | -9.15% | $21.00* | 59.9K | Apr 4, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Options Exercise | $1K | +168 | +0.28% | $5.97 | 60.1K | Apr 4, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Sale | -$3.53K | -168 | -0.28% | $21.00* | 59.9K | Apr 4, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Options Exercise | $29.9K | +1.78K | +2.96% | $16.82* | 61.7K | Apr 4, 2022 | Direct | F1 |
transaction | ACET | Common Stock | Sale | -$37.3K | -1.78K | -2.88% | $21.00* | 59.9K | Apr 4, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACET | Employee Stock Option (Right to Buy) | Options Exercise | -7.62K | -6.28% | 114K | Apr 1, 2022 | Common Stock | 7.62K | $5.97 | Direct | F1, F2, F3 | ||
transaction | ACET | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -6.04K | -7.55% | $0.00 | 74K | Apr 4, 2022 | Common Stock | 6.04K | $13.27 | Direct | F1, F4 |
transaction | ACET | Employee Stock Option (Right to Buy) | Options Exercise | -168 | -0.15% | 114K | Apr 4, 2022 | Common Stock | 168 | $5.97 | Direct | F1, F2, F3 | ||
transaction | ACET | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.78K | -6.25% | $0.00 | 26.6K | Apr 4, 2022 | Common Stock | 1.78K | $16.82 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on April 30, 2021. |
F2 | A total of 128,424 shares subject to an employee stock option were received as described in footnote (3). 25% of the shares vested on September 23, 2020, and 1/36th of the remaining unvested shares vest on each of the next thirty-six (36) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting date. |
F3 | Received in exchange for an employee stock option to acquire 1,035,685 shares of common stock of Adicet Bio, Inc., a Delaware corporation ("Old Adicet"), for $0.740 per share in connection with the merger (the "Merger") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation ("resTORbio"). On the effective date of the Merger, resTORbio changed its name to "Adicet Bio, Inc." |
F4 | A total of 80,000 shares subject to an employee stock option were granted on January 13, 2021, with 1/48th of the shares vesting on each of the next forty-eight (48) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting dates. |
F5 | A total of 28,400 shares subject to an employee stock option were granted on February 12, 2021, with 1/48th of the shares vesting on each of the next forty-eight (48) monthly anniversaries thereafter, provided that the Reporting Person remains in continuous service as of the applicable vesting dates. |